American Portfolios Advisors Esperion Therapeutics, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 46,490 shares of ESPR stock, worth $103,207. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,490
Holding current value
$103,207
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$5.45 - $8.13 $253,370 - $377,963
46,490 New
46,490 $311 Million
Q2 2022

Mar 20, 2023
SELL
$4.77 - $6.67 $16,885 - $23,611
-3,540 Reduced 7.61%
42,950 $273 Million
Q1 2022

Mar 21, 2023
SELL
$3.34 - $5.56 $11,823 - $19,682
-3,540 Reduced 7.61%
42,950 $199 Million
Q4 2021

Mar 21, 2023
SELL
$4.81 - $11.92 $18,157 - $44,998
-3,775 Reduced 8.12%
42,715 $214 Million
Q3 2021

Mar 22, 2023
SELL
$11.34 - $21.37 $191,986 - $361,794
-16,930 Reduced 36.42%
29,560 $356 Million
Q2 2021

Mar 22, 2023
SELL
$19.4 - $28.71 $350,267 - $518,359
-18,055 Reduced 38.84%
28,435 $601 Million
Q1 2021

Mar 22, 2023
SELL
$25.12 - $36.89 $538,321 - $790,552
-21,430 Reduced 46.1%
25,060 $703 Million
Q4 2020

Mar 22, 2023
SELL
$24.2 - $35.76 $588,181 - $869,146
-24,305 Reduced 52.28%
22,185 $577 Million
Q3 2020

Mar 22, 2023
SELL
$31.18 - $52.71 $798,052 - $1.35 Million
-25,595 Reduced 55.05%
20,895 $777 Million
Q2 2020

Mar 24, 2023
BUY
$30.04 - $51.31 $87,416 - $149,312
2,910 Added 24.57%
14,755 $757 Million
Q1 2020

Mar 24, 2023
SELL
$27.44 - $73.84 $950,658 - $2.56 Million
-34,645 Reduced 74.52%
11,845 $373 Million
Q4 2019

Mar 24, 2023
SELL
$35.4 - $59.82 $1.49 Million - $2.52 Million
-42,070 Reduced 90.49%
4,420 $264 Million
Q3 2019

Mar 24, 2023
BUY
$34.47 - $47.53 $6,894 - $9,506
200 Added 4.98%
4,220 $155 Million
Q2 2019

Mar 24, 2023
SELL
$40.1 - $52.33 $1.7 Million - $2.22 Million
-42,470 Reduced 91.35%
4,020 $187 Million
Q1 2019

Mar 24, 2023
BUY
$40.11 - $53.57 $19,052 - $25,445
475 Added 12.35%
4,320 $173 Million
Q3 2018

Mar 24, 2023
SELL
$40.74 - $51.41 $1.74 Million - $2.19 Million
-42,645 Reduced 91.73%
3,845 $171 Million
Q2 2018

Mar 24, 2023
SELL
$36.2 - $76.4 $84,346 - $178,012
-2,330 Reduced 42.56%
3,145 $123 Million
Q1 2018

Mar 24, 2023
SELL
$65.94 - $80.76 $2.7 Million - $3.31 Million
-41,015 Reduced 88.22%
5,475 $396 Million
Q4 2017

Mar 24, 2023
SELL
$43.47 - $67.43 $1.78 Million - $2.77 Million
-41,015
5,475 $360 Million

Others Institutions Holding ESPR

# of Institutions
174
Shares Held
125M
Call Options Held
2.08M
Put Options Held
1.01M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $148M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email